How to Fill Out SEC Form 10-Q (w/Examples) + FAQs

Filing SEC Form 10-Q is the quarterly report most U.S. public companies must submit to the Securities and Exchange Commission for each of the first three fiscal quarters. The form gives investors an unaudited, near-real-time look at a company’s finances, risks, and operations under Section 13(a) of the Securities Exchange Act of 1934.

Missing the deadline or filing a sloppy 10-Q can trigger loss of Form S-3 shelf eligibility, exchange delisting, and private securities lawsuits under Rule 10b-5. According to the SEC’s 2024 Agency Financial Report, the Division of Enforcement filed 583 standalone actions in fiscal 2024, with disclosure failures among the top categories.

Here is what you will learn in this guide:

What Is SEC Form 10-Q?

Form 10-Q is the quarterly report required by Rule 13a-13 for issuers with securities registered under Section 12 of the Exchange Act, and by Rule 15d-13 for issuers with reporting duties under Section 15(d). The form covers the first three fiscal quarters of the year. The fourth quarter is rolled into the annual Form 10-K instead.

The 10-Q is an unaudited filing. That means the financial statements inside it are reviewed by the independent auditor under PCAOB Auditing Standard 4105, but they are not audited like the annual statements. The review is lighter, faster, and cheaper, but it still puts pressure on the numbers to be accurate.

The plain-English purpose of the 10-Q is transparency. Investors trade on quarterly updates, and the SEC wants the market to have current, decision-useful information. The consequence of skipping or shortcutting the 10-Q is that a company can lose its current public-information status and become ineligible for streamlined offerings under Form S-3.

A common misconception is that the 10-Q is just a longer version of the quarterly earnings press release. It is not. The earnings release is a marketing document filed on Form 8-K Item 2.02, while the 10-Q is a full legal disclosure with certifications, controls, and liability under Section 18 of the Exchange Act.

For example, Maria, the CFO of a mid-cap software company, treats the earnings release as a sales tool but treats the 10-Q as a legal filing reviewed by counsel and the audit committee. Skipping that distinction is how companies end up with restatements and SEC comment letters from the Division of Corporation Finance.

Who Must File Form 10-Q?

Any company with a class of securities registered under Section 12 of the Exchange Act, or that has a Section 15(d) reporting obligation from a past registered offering, generally must file a 10-Q. Foreign private issuers do not file 10-Qs. They use Form 6-K and Form 20-F instead.

Smaller reporting companies (SRCs) get a scaled disclosure regime under Regulation S-K Item 10(f) and Article 8 of Regulation S-X. Emerging growth companies (EGCs) under the JOBS Act get reduced executive compensation disclosure and a temporary auditor-attestation exemption under SOX §404(b).

The consequence of filing the wrong scaled disclosure is rejection or a comment letter from SEC staff. David, the controller at a newly public biotech, learned this when his team filed full Item 305 market risk disclosure even though the company qualified as an SRC and could have omitted it under Item 305(e).

A common misconception is that private companies that issued public debt are off the hook. They are not. If they registered the debt under the Securities Act of 1933, they almost always have a Section 15(d) duty and must file 10-Qs until the duty is suspended.

Domestic Filer Categories

The SEC sorts domestic filers into four buckets that drive deadlines: large accelerated, accelerated, non-accelerated, and smaller reporting companies. The categories live in Rule 12b-2. Public float and revenue thresholds, updated by the SEC’s 2020 amendments, set the line.

Large accelerated filers have a public float of \$700 million or more. Accelerated filers have a float between \$75 million and \$700 million and revenue of \$100 million or more. Non-accelerated filers fall below those marks. The consequence of misclassifying yourself is a missed deadline, because the deadline depends on the category.

Foreign Private Issuers

A foreign private issuer (FPI) under Rule 3b-4 does not file 10-Qs. Instead, the FPI furnishes interim reports on Form 6-K whenever it makes them public abroad. The annual filing is Form 20-F.

The consequence of misjudging FPI status is filing the wrong form set, which can confuse investors and trigger staff review. Lin, the general counsel at a Cayman-domiciled holding company, runs the FPI test every June 30 because losing FPI status mid-year forces a switch to domestic forms the next fiscal year.

Form 10-Q Filing Deadlines

The deadline depends on filer status under Rule 13a-13. Large accelerated and accelerated filers must file within 40 days after the end of the fiscal quarter. Non-accelerated filers and smaller reporting companies get 45 days.

The clock starts on the day after the quarter ends. For a calendar-year large accelerated filer, the Q1 10-Q is due about May 10, the Q2 10-Q is due about August 9, and the Q3 10-Q is due about November 9. There is no Q4 10-Q because the Form 10-K takes its place.

If a deadline falls on a weekend or federal holiday, Rule 0-3 pushes it to the next business day. Filings are submitted through the EDGAR system by 5:30 p.m. Eastern Time to count as filed that day.

The consequence of missing the deadline is steep. The company must file Form 12b-25, often called an NT 10-Q, to claim a five-business-day extension. Even with the extension, a late 10-Q knocks the issuer out of Form S-3 shelf eligibility for twelve months and can trigger covenant defaults in credit agreements.

A common misconception is that an NT 10-Q automatically buys five extra days with no harm. It does not. The company must certify that the delay could not be eliminated without unreasonable effort or expense, and the late filing still appears as a black mark in the SEC’s full-text search.

Structure of Form 10-Q

Form 10-Q has two main parts. Part I covers financial information. Part II covers other information, including legal proceedings and risk factor updates. Each part has numbered items that map to specific Regulation S-K and Regulation S-X requirements.

The form starts with a cover page. The cover page captures the registrant’s name, state of incorporation, IRS Employer Identification Number, address, telephone, trading symbol, exchange, and filer status checkboxes. The cover page is now Inline-XBRL-tagged under Rule 405 of Regulation S-T.

The consequence of an inaccurate cover page is more than cosmetic. Wrong filer status drives wrong deadlines and wrong scaled disclosure choices. Priya, a securities paralegal, double-checks the cover page against the public float worksheet every quarter to avoid that snowball.

How to Fill Out Part I: Financial Information

Part I is the heart of the 10-Q. It contains the unaudited financial statements, MD&A, market risk disclosure, and controls disclosure. Each item below has its own rules, and each one carries its own consequence if you skip a step.

Item 1: Financial Statements

Item 1 requires unaudited interim financial statements prepared under Article 10 of Regulation S-X. Larger filers include a balance sheet, income statement, statement of comprehensive income, statement of cash flows, and statement of stockholders’ equity. SRCs may use the simpler Article 8 format.

The statements must be reviewed by an independent registered public accounting firm under PCAOB AS 4105 before filing. The auditor does not issue an opinion. The auditor performs analytical procedures and inquiries to provide limited assurance.

The consequence of filing without a SAS-style review is a deficient filing that staff will challenge. Ahmed, a CFO at a recently IPO’d company, learned that lesson when his auditor refused to clear the 10-Q because management had not provided the representation letter on time.

A common misconception is that the interim statements can ignore new accounting standards until year-end. They cannot. Companies must adopt ASC standards in the interim period required by the standard’s effective date and disclose the transition method.

Item 2: Management’s Discussion and Analysis (MD&A)

Item 2 requires MD&A under Regulation S-K Item 303. MD&A must explain results of operations, liquidity, capital resources, and known trends or uncertainties that are reasonably likely to materially affect the company. The SEC modernized Item 303 in Release 33-10890 in 2020.

Good MD&A is forward-looking and analytical, not just a numerical recap. The SEC’s 2003 interpretive release tells issuers to discuss the reasons underlying changes, not just the changes themselves. A 10-percent revenue jump should be explained by volume, price, mix, or acquisition effects.

The consequence of weak MD&A is a comment letter, and in serious cases, an enforcement action. The SEC sued a public company in SEC v. Hertz Global Holdings for misleading MD&A and disclosure failures, leading to a \$16 million civil penalty.

A common misconception is that MD&A is just a finance team document. It is not. Operations, sales, and legal must all weigh in, because known trends often originate outside accounting. Sofia, the head of FP&A at a retailer, runs a cross-functional MD&A meeting every quarter to surface trend language that the controller alone would miss.

Item 3: Quantitative and Qualitative Disclosures About Market Risk

Item 3 incorporates Regulation S-K Item 305. It requires disclosure of market risk exposures from interest rate, foreign currency, commodity, and equity price changes. Companies present the risk in tabular, sensitivity, or value-at-risk form.

SRCs are exempt from Item 305 under Item 305(e). EGCs are not automatically exempt from Item 305 but often qualify as SRCs and benefit indirectly. The consequence of mislabeling exposures is a comment letter forcing an amendment.

A common misconception is that companies without derivatives have nothing to disclose. They do. Even a company with only floating-rate debt has interest-rate risk that must be quantified.

Item 4: Controls and Procedures

Item 4 requires disclosure of disclosure controls and procedures under Rule 13a-15(e) and any change in internal control over financial reporting (ICFR) that materially affected, or is reasonably likely to materially affect, ICFR. Management must conclude on the effectiveness of disclosure controls as of the end of the quarter.

The CEO and CFO sign off through SOX §302 certifications attached as exhibits. A material weakness identified during the quarter must be discussed in Item 4 and often in MD&A as well.

The consequence of failing to disclose a known material weakness is severe. The SEC has brought enforcement actions, including In the Matter of Magnachip Semiconductor, where ICFR failures contributed to a multi-million-dollar penalty.

A common misconception is that a small company can rely on a single CFO sign-off without testing. It cannot. The certification language under Rule 13a-14 requires actual evaluation, and false certifications carry §906 criminal penalties of up to \$5 million and 20 years in prison for willful violations.

How to Fill Out Part II: Other Information

Part II contains six items that round out the disclosure picture. Each item is conditional. If nothing happened during the quarter, the company simply states “None.”

Item 1: Legal Proceedings

Item 1 incorporates Regulation S-K Item 103. The company must disclose material pending legal proceedings other than ordinary, routine litigation incidental to the business. Environmental proceedings with the government must be disclosed if monetary sanctions are reasonably likely to exceed a threshold the company elected (default \$300,000) under the SEC’s 2020 amendments.

The consequence of omitting a material proceeding is exposure under Rule 10b-5. The Supreme Court’s decision in Matrixx Initiatives v. Siracusano, 563 U.S. 27 (2011) confirmed that materiality is contextual, and even statistically insignificant adverse events can be material if a reasonable investor would view them as altering the total mix.

Item 1A: Risk Factors

Item 1A only requires disclosure of material changes from the risk factors in the most recent 10-K, under Item 105 of Regulation S-K. Companies do not need to repeat the full 10-K risk factor section.

The consequence of failing to update is twofold. The market loses notice of evolving risks, and plaintiffs gain a road map for a 10b-5 case. Jamal, the deputy GC at a fintech, updates risk factors every quarter to reflect new regulatory developments at the CFPB and state regulators.

A common misconception is that boilerplate is safe. It is not. The SEC’s 2019 Investor Advisory Committee remarks flagged generic risk factors as a top staff concern.

Item 2: Unregistered Sales of Equity Securities and Use of Proceeds

Item 2 covers Regulation S-K Items 701 and 703 and requires disclosure of any unregistered equity sales during the quarter, the exemption relied on (such as Section 4(a)(2) or Rule 506), and use of proceeds from registered offerings. Issuer share repurchases are also disclosed in tabular form.

The consequence of skipping repurchase disclosure is a comment letter and possible Rule 10b-18 safe-harbor problems under Rule 10b-18. The SEC’s 2023 buyback amendments imposed daily quantitative tagging requirements that issuers must follow.

Item 3: Defaults Upon Senior Securities

Item 3 captures any material default in principal, interest, or sinking-fund payments on senior debt, and any arrearage on preferred stock dividends. The consequence of nondisclosure is severe because lenders, rating agencies, and investors all rely on this datapoint.

A common misconception is that a cured default does not need to be disclosed. It does. Disclosure is triggered if the default occurred during the quarter, even if the company cured it before filing.

Item 4: Mine Safety Disclosures

Item 4 applies only to issuers that operate coal or other mines under Section 1503 of Dodd-Frank. Most companies write “Not applicable.” The consequence of overlooking it for a mining issuer is a stand-alone enforcement risk under Item 104 of Regulation S-K.

Item 5: Other Information

Item 5 is a catch-all. As of the SEC’s Insider Trading Arrangements rule (Release 33-11138), issuers must disclose adoption, modification, or termination of Rule 10b5-1 trading arrangements by directors and officers. Item 5 also captures information that should have been on a Form 8-K but was not.

The consequence of using Item 5 to bury news is reputational and legal. Investors and the staff notice when an 8-K-worthy item gets parked in a 10-Q footnote.

Item 6: Exhibits

Item 6 lists the exhibits required by Item 601 of Regulation S-K. Standard exhibits include the §302 certifications, §906 certifications, and the Inline XBRL data files. Material contracts entered during the quarter are filed here too.

The consequence of missing a certification is fatal. The 10-Q is considered deficient and the issuer loses current public-information status under Rule 144(c).

SOX §302 and §906 Certifications

SOX §302 requires the principal executive officer and principal financial officer to certify, among other things, that they reviewed the report, that it does not contain a material misstatement or omission, and that the financial statements fairly present the company’s financial condition. The exact language is dictated by Item 601(b)(31) and cannot be modified.

SOX §906 is a separate criminal certification. It states that the report fully complies with the Exchange Act and fairly presents the financial condition of the issuer. Knowing violations can result in fines up to \$1 million and imprisonment up to 10 years; willful violations can reach \$5 million and 20 years.

The consequence of a defective certification is enforcement risk for the officers personally, not just the company. The SEC has charged CEOs and CFOs individually under SOX §304, which allows clawback of bonuses and stock profits when an issuer restates due to misconduct.

Inline XBRL Tagging Requirements

Since 2019, the SEC has required Inline XBRL for financial statement data and cover page data under Rule 405 of Regulation S-T. Inline XBRL embeds machine-readable tags into the human-readable HTML, letting investors and the SEC’s EDGAR parse the document automatically.

The taxonomy is the US-GAAP Financial Reporting Taxonomy maintained by the FASB. Custom extensions are allowed only when no standard tag fits. Overuse of extensions is a top staff comment area.

The consequence of bad tagging is a DERA error report, late acceptance, or in some cases an amendment. Carla, an XBRL specialist, runs every 10-Q through validation tools before submission to catch sign-flips and decimals errors.

Three Common 10-Q Scenarios

Below are three scenarios that show how form decisions translate into outcomes. Each shows the choice and the consequence.

Filing Choice Outcome
Filer files Q2 10-Q two days late without an NT 10-Q Loss of Form S-3 eligibility for 12 months and a public-information gap under Rule 144
Filer omits a known material weakness from Item 4 SEC enforcement risk under Rule 13a-15 and shareholder suits under Rule 10b-5
Filer uses boilerplate risk factors with no updates Comment letter from Corp Fin and exposure under Item 105
MD&A Approach Result
Quantitative recap only, no causes given Comment letter under Item 303 and Release 33-8350
Full driver analysis with known trends Lower comment letter risk and stronger investor confidence
Forward-looking statements without PSLRA safe-harbor language Loss of safe-harbor protection in private securities litigation
Certification Practice Effect
CEO signs §302 without reviewing disclosure controls Personal exposure under SOX §302 and possible §304 clawback
CFO drafts certification language verbatim from Item 601 Compliant certification accepted by EDGAR
Officer files §906 with knowledge of misstatement Criminal liability under 18 U.S.C. §1350

Mistakes to Avoid

  • Filing late without Form 12b-25, which costs the company S-3 eligibility for a year.
  • Copying last quarter’s MD&A without updating known trends, which violates Item 303.
  • Using boilerplate risk factors with no quarter-specific updates under Item 105.
  • Skipping the §302 certification language exactly as written, which makes the filing deficient.
  • Ignoring a material weakness in Item 4, which exposes officers under Rule 13a-15.
  • Forgetting Rule 10b5-1 plan disclosures under Item 5 of Part II.
  • Submitting deficient Inline XBRL tags or overusing custom extensions.
  • Using last year’s filer status when float crossed the \$700 million large accelerated threshold.
  • Burying 8-K-worthy events in Item 5 instead of filing a current report on Form 8-K.
  • Letting the auditor’s SAS 100 / AS 4105 review slip past the deadline.

Do’s and Don’ts

Do’s:

  • Do build a quarterly disclosure committee that meets before every 10-Q, because Release 33-8124 treats the committee as a best practice for §302 certifications.
  • Do tag all numerical and narrative data with Inline XBRL using standard tags whenever possible to avoid extension comments.
  • Do reconcile non-GAAP measures under Regulation G and Item 10(e) of Regulation S-K to prevent SEC pushback.
  • Do file Form 12b-25 as soon as you suspect a delay because the form must be filed no later than one business day after the original deadline.
  • Do log all director and officer trades against Rule 10b5-1 plans so that Item 5 disclosures are accurate.

Don’ts:

  • Do not modify the §302 certification language because the SEC requires verbatim text.
  • Do not rely on the auditor to draft MD&A; Item 303 is management’s responsibility.
  • Do not assume immateriality protects you from disclosure; Matrixx made materiality contextual.
  • Do not file financial statements that ignore newly effective FASB ASC standards.
  • Do not skip the PSLRA safe-harbor legend before forward-looking statements.

Pros and Cons of Quarterly 10-Q Reporting

Pros:

  • Provides timely disclosure under Rule 13a-13, keeping markets informed.
  • Maintains Form S-3 shelf eligibility for streamlined capital raises.
  • Reinforces SOX §302 and §906 accountability at the officer level.
  • Keeps ICFR testing on a steady cadence.
  • Builds investor trust through transparent MD&A trend disclosure.

Cons:

Key Court Rulings That Shape 10-Q Disclosure

Basic Inc. v. Levinson, 485 U.S. 224 (1988) created the “fraud-on-the-market” theory and confirmed the materiality standard tied to “total mix” of information. The decision drives how MD&A and risk factors are drafted in 10-Qs.

Matrixx Initiatives v. Siracusano, 563 U.S. 27 (2011) held that pharmaceutical adverse events can be material even without statistical significance. The case raised the bar for risk factor and Item 103 legal proceedings disclosure.

Halliburton Co. v. Erica P. John Fund, 573 U.S. 258 (2014) preserved fraud-on-the-market while letting defendants rebut price impact. The ruling makes accurate, timely 10-Q disclosure central to defending securities suits.

Penalties for Late or Deficient 10-Qs

Form 12b-25, the Notification of Late Filing, gives a five-business-day grace period for 10-Qs. Even with the grace period, the issuer signals trouble to the market.

A late 10-Q removes the company from Form S-3 eligibility for 12 months. The company also fails the “current public information” requirement of Rule 144(c)(1), which freezes affiliate resales and chills insider liquidity.

Exchanges respond too. NYSE Listed Company Manual §802.01E and Nasdaq Listing Rule 5250(c) impose listing notifications and possible delisting for chronic late filers.

The SEC may bring enforcement actions, including suspensions of trading under Section 12(j) of the Exchange Act when issuers fail to file periodic reports.

State-Level Considerations

Federal law dominates 10-Q filings, but state law still matters. Delaware’s General Corporation Law §220 gives stockholders inspection rights that often lean on the same financial information disclosed in the 10-Q.

State Blue Sky laws are largely preempted by NSMIA for federally covered securities, so state regulators rarely re-review the 10-Q itself. However, state attorneys general and securities administrators can act under state anti-fraud laws, such as California Corporations Code §25401, if a 10-Q misstatement injures state residents.

Public retirement systems, such as CalPERS, often serve as lead plaintiffs in 10b-5 class actions tied to defective 10-Q disclosures. Mark, the assistant treasurer at a manufacturer, treats institutional investor outreach as a quarterly risk-management exercise.

Practical Filing Workflow on EDGAR

Filers submit 10-Qs through EDGAR using filer credentials issued under Form ID. The submission must use the correct submission type (10-Q, 10-Q/A for amendments, NT 10-Q for late notice).

Filers should test submissions in the EDGAR Filer Manual sandbox before live filing. The sandbox catches XBRL validation errors that would otherwise delay acceptance.

The consequence of a failed live submission near the 5:30 p.m. ET cutoff is a missed deadline. Many filers aim for a 2:00 p.m. ET internal cutoff to leave room for corrections.

FAQs

Is Form 10-Q required every quarter?

No. A 10-Q is filed for the first three fiscal quarters under Rule 13a-13. The fourth quarter is rolled into the annual Form 10-K.

Are 10-Q financial statements audited?

No. They are reviewed by the independent auditor under PCAOB AS 4105. The review provides limited assurance, not an audit opinion, and is faster than a year-end audit.

Can a smaller reporting company file a simplified 10-Q?

Yes. SRCs may follow Article 8 of Regulation S-X and scaled Regulation S-K items, including exemption from market risk disclosure under Item 305(e).

Does a missed 10-Q affect Form S-3 eligibility?

Yes. A late 10-Q knocks the issuer out of Form S-3 eligibility for 12 months under General Instruction I.A.3, blocking shelf takedowns during that period.

Must I file a Form 12b-25 for a late 10-Q?

Yes. Rule 12b-25 requires the notification within one business day of the original deadline to claim the five-business-day grace period.

Are §906 certifications criminal?

Yes. 18 U.S.C. §1350 imposes fines up to \$5 million and imprisonment up to 20 years for willful false certifications, separate from §302 civil exposure.

Do foreign private issuers file 10-Qs?

No. FPIs furnish Form 6-K for interim reports and file Form 20-F annually under Rule 3b-4.

Is Inline XBRL mandatory for 10-Qs?

Yes. Rule 405 of Regulation S-T requires Inline XBRL for financial statements and cover page data for all operating company filers.

Can I update risk factors only when something changed?

Yes. Item 1A of Form 10-Q requires only material changes from the prior 10-K’s Item 105 risk factors, not a full repeat.

Does Item 5 of Part II require disclosure of 10b5-1 plans?

Yes. Under Release 33-11138, issuers must disclose adoption, modification, or termination of Rule 10b5-1 plans by directors and officers each quarter.

Are non-GAAP measures allowed in MD&A?

Yes. Non-GAAP measures are allowed if reconciled per Regulation G and Item 10(e) of Regulation S-K, with the most directly comparable GAAP measure given equal or greater prominence.

Can shareholders sue over a defective 10-Q?

Yes. Private actions under Rule 10b-5 and Section 18 of the Exchange Act allow shareholders to sue for material misstatements or omissions in 10-Qs.